Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? (Q34549650)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both?	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Treatment strategies in patients with chronic renal disease: ACE inhibitors, angiotensin receptor antagonists, or both? (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

main subject

chronic renal disease

1 reference

based on heuristic

inferred from title

author name string

Karl F Hilgers

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

Jörg Dötsch

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

Wolfgang Rascher

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

Johannes F E Mann

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

publication date

22 July 2004

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

published in

Pediatric Nephrology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

volume

19

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

issue

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

page(s)

956-961

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

cites work

Enalapril in paediatric patients with Alport syndrome: 2 years' experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Add-on angiotensin receptor blockade with maximized ACE inhibition

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preservation of kidney function by use of converting-enzyme inhibitors for control of hypertension

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The acute renal effects of angiotensin II receptor blockers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiproteinuric effects of enalapril and losartan: a pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors for reduction of proteinuria in children with steroid-resistant nephrotic syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enalapril in children with Alport syndrome

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Home, clinic, and ambulatory blood pressure monitoring in children with chronic renal failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual renin-angiotensin system blockade at optimal doses for proteinuria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin's role in renal development

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin converting enzyme inhibitors and reflux nephropathy: 2-year follow-up

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, dose–response study of the effectiveness and safety of lisinopril for children with hypertension

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibition in the treatment of children after renal transplantation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effectiveness and safety of the angiotensin II antagonist irbesartan in children with chronic kidney diseases

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

International union of pharmacology. XXIII. The angiotensin II receptors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A double-blind, placebo-controlled, dose-response study of the effectiveness and safety of enalapril for children with hypertension

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ACE inhibitors versus AT(1) receptor antagonists in patients with chronic renal disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/15278690

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00467-004-1554-5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

Dimensions Publication ID

1049081073

0 references

PubMed publication ID

15278690

1 reference

stated in

Europe PubMed Central

PubMed publication ID

15278690

retrieved

3 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34549650&oldid=2196768930"